242 related articles for article (PubMed ID: 34731055)
1. Diversification of a Fucosyllactose Transporter within the Genus
Ojima MN; Asao Y; Nakajima A; Katoh T; Kitaoka M; Gotoh A; Hirose J; Urashima T; Fukiya S; Yokota A; Abou Hachem M; Sakanaka M; Katayama T
Appl Environ Microbiol; 2022 Jan; 88(2):e0143721. PubMed ID: 34731055
[TBL] [Abstract][Full Text] [Related]
2. Fucosylated Human Milk Oligosaccharide Foraging within the Species Bifidobacterium pseudocatenulatum Is Driven by Glycosyl Hydrolase Content and Specificity.
Shani G; Hoeflinger JL; Heiss BE; Masarweh CF; Larke JA; Jensen NM; Wickramasinghe S; Davis JC; Goonatilleke E; El-Hawiet A; Nguyen L; Klassen JS; Slupsky CM; Lebrilla CB; Mills DA
Appl Environ Microbiol; 2022 Jan; 88(2):e0170721. PubMed ID: 34757822
[TBL] [Abstract][Full Text] [Related]
3. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense.
Bunesova V; Lacroix C; Schwab C
BMC Microbiol; 2016 Oct; 16(1):248. PubMed ID: 27782805
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis.
Sakanaka M; Hansen ME; Gotoh A; Katoh T; Yoshida K; Odamaki T; Yachi H; Sugiyama Y; Kurihara S; Hirose J; Urashima T; Xiao JZ; Kitaoka M; Fukiya S; Yokota A; Lo Leggio L; Abou Hachem M; Katayama T
Sci Adv; 2019 Aug; 5(8):eaaw7696. PubMed ID: 31489370
[TBL] [Abstract][Full Text] [Related]
5. Varied Pathways of Infant Gut-Associated
Sakanaka M; Gotoh A; Yoshida K; Odamaki T; Koguchi H; Xiao JZ; Kitaoka M; Katayama T
Nutrients; 2019 Dec; 12(1):. PubMed ID: 31888048
[TBL] [Abstract][Full Text] [Related]
6. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.
Asakuma S; Hatakeyama E; Urashima T; Yoshida E; Katayama T; Yamamoto K; Kumagai H; Ashida H; Hirose J; Kitaoka M
J Biol Chem; 2011 Oct; 286(40):34583-92. PubMed ID: 21832085
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal.
James K; Bottacini F; Contreras JIS; Vigoureux M; Egan M; Motherway MO; Holmes E; van Sinderen D
Sci Rep; 2019 Oct; 9(1):15427. PubMed ID: 31659215
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides.
Yoshida E; Sakurama H; Kiyohara M; Nakajima M; Kitaoka M; Ashida H; Hirose J; Katayama T; Yamamoto K; Kumagai H
Glycobiology; 2012 Mar; 22(3):361-8. PubMed ID: 21926104
[TBL] [Abstract][Full Text] [Related]
9. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve.
Ruiz-Moyano S; Totten SM; Garrido DA; Smilowitz JT; German JB; Lebrilla CB; Mills DA
Appl Environ Microbiol; 2013 Oct; 79(19):6040-9. PubMed ID: 23892749
[TBL] [Abstract][Full Text] [Related]
10. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum.
Gotoh A; Katoh T; Sakanaka M; Ling Y; Yamada C; Asakuma S; Urashima T; Tomabechi Y; Katayama-Ikegami A; Kurihara S; Yamamoto K; Harata G; He F; Hirose J; Kitaoka M; Okuda S; Katayama T
Sci Rep; 2018 Sep; 8(1):13958. PubMed ID: 30228375
[TBL] [Abstract][Full Text] [Related]
11. Human Milk Oligosaccharide Utilization in Intestinal Bifidobacteria Is Governed by Global Transcriptional Regulator NagR.
Arzamasov AA; Nakajima A; Sakanaka M; Ojima MN; Katayama T; Rodionov DA; Osterman AL
mSystems; 2022 Oct; 7(5):e0034322. PubMed ID: 36094076
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction of the Bifidobacterial Pan-Secretome Reveals the Network of Extracellular Interactions between Bifidobacteria and the Infant Gut.
Lugli GA; Mancino W; Milani C; Duranti S; Turroni F; van Sinderen D; Ventura M
Appl Environ Microbiol; 2018 Aug; 84(16):. PubMed ID: 29884754
[TBL] [Abstract][Full Text] [Related]
13. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria.
Garrido D; Ruiz-Moyano S; Lemay DG; Sela DA; German JB; Mills DA
Sci Rep; 2015 Sep; 5():13517. PubMed ID: 26337101
[TBL] [Abstract][Full Text] [Related]
14. Infant Gut Microbial Metagenome Mining of α-l-Fucosidases with Activity on Fucosylated Human Milk Oligosaccharides and Glycoconjugates.
Moya-Gonzálvez EM; Peña-Gil N; Rubio-Del-Campo A; Coll-Marqués JM; Gozalbo-Rovira R; Monedero V; Rodríguez-Díaz J; Yebra MJ
Microbiol Spectr; 2022 Aug; 10(4):e0177522. PubMed ID: 35943155
[TBL] [Abstract][Full Text] [Related]
15. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization.
LoCascio RG; Desai P; Sela DA; Weimer B; Mills DA
Appl Environ Microbiol; 2010 Nov; 76(22):7373-81. PubMed ID: 20802066
[TBL] [Abstract][Full Text] [Related]
16. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota.
Yu ZT; Chen C; Kling DE; Liu B; McCoy JM; Merighi M; Heidtman M; Newburg DS
Glycobiology; 2013 Feb; 23(2):169-77. PubMed ID: 23028202
[TBL] [Abstract][Full Text] [Related]
17. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.
Vandenplas Y; Berger B; Carnielli VP; Ksiazyk J; Lagström H; Sanchez Luna M; Migacheva N; Mosselmans JM; Picaud JC; Possner M; Singhal A; Wabitsch M
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149573
[TBL] [Abstract][Full Text] [Related]
18. Milk oligosaccharide-driven persistence of Bifidobacterium pseudocatenulatum modulates local and systemic microbial metabolites upon synbiotic treatment in conventionally colonized mice.
Larke JA; Heiss BE; Ehrlich AM; Taft DH; Raybould HE; Mills DA; Slupsky CM
Microbiome; 2023 Aug; 11(1):194. PubMed ID: 37635250
[TBL] [Abstract][Full Text] [Related]
19. Host-derived glycans serve as selected nutrients for the gut microbe: human milk oligosaccharides and bifidobacteria.
Katayama T
Biosci Biotechnol Biochem; 2016; 80(4):621-32. PubMed ID: 26838671
[TBL] [Abstract][Full Text] [Related]
20. Selective Utilization of the Human Milk Oligosaccharides 2'-Fucosyllactose, 3-Fucosyllactose, and Difucosyllactose by Various Probiotic and Pathogenic Bacteria.
Salli K; Hirvonen J; Siitonen J; Ahonen I; Anglenius H; Maukonen J
J Agric Food Chem; 2021 Jan; 69(1):170-182. PubMed ID: 33382612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
